superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2025-09-30
- Valid until
- 2026-03-31
- Published
- 2025-11-05
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 8,618,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Amgen quarterly revenue: 9,557,000,000 United States dollar", as of 2025-09-30 (until 2026-03-31). Claim clm_56EFD8BFD444, https://asof.is/claim/clm_56EFD8BFD444, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm.
APA
AsOf. (2025). Amgen quarterly revenue: 9,557,000,000 United States dollar (as of 2025-09-30 (until 2026-03-31)) [Record clm_56EFD8BFD444]. Retrieved November 8, 2026, from https://asof.is/claim/clm_56EFD8BFD444 (source: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm)
BibTeX
@misc{asof_clm_56EFD8BFD444,
author = {AsOf},
title = {Amgen quarterly revenue: 9,557,000,000 United States dollar},
year = {2025},
howpublished = {\url{https://asof.is/claim/clm_56EFD8BFD444}},
note = {Claim clm\_56EFD8BFD444, as of 2025-09-30 (until 2026-03-31); source: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_56EFD8BFD444.md/v1/claims/clm_56EFD8BFD444submit a correction